<DOC>
	<DOCNO>NCT00418600</DOCNO>
	<brief_summary>Hectorol safe effective treatment secondary hyperparathyroidism hemodialysis patient . Hectorol ( doxercalciferol capsule ) indicate treatment secondary hyperparathyroidism patient chronic kidney disease dialysis pre-dialysis patient Stage 3 Stage 4 chronic kidney disease . Hectorol ( doxercalciferol injection ) indicate treatment secondary hyperparathyroidism patient chronic kidney disease dialysis . This protocol determine clinically appropriate dos Hectorol ( doxercalciferol capsule ) convert subject Hectorol ( doxercalciferol injection . ) The study enroll hemodialysis patient control intravenous Hectorol . information gain study useful guide physicians manage CKD Stage 5 patient change intravenous oral vitamin D administration appropriate .</brief_summary>
	<brief_title>A Phase 4 , Conversion Study Hectorol速 Injection Hectorol速 Capsules Stage 5 CKD Patients Dialysis</brief_title>
	<detailed_description />
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>1 alpha-hydroxyergocalciferol</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>The subject must receive hemodialysis three time per week minimum six month . The subject must receive Hectorol Injection minimum 3 month . The subject must stable dose regimen , three time per week administration minimum four week . The central laboratory assessment must within follow range : serum iPTH 150600 pg/mL , inclusive ; correct calcium &lt; 10.0 mg/dL ; phosphorus &lt; 7.0 mg/dL . In opinion Investigator , subject currently poorly control diabetes mellitus , poorly control hypertension , active vasculitis , HIV infection , clinically significant , unstable medical condition . Abnormal liver function measure ALT/AST great two time upper limit normal ( ULN ) . The subject currently malabsorption , severe chronic diarrhea , ileostomy . Any evidence active malignancy except basal cell carcinoma skin . A history malignancy exclusion . Current use aluminum magnesium base binder .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2015</verification_date>
	<keyword>Secondary Hyperparathyroidism</keyword>
	<keyword>Hectorol速 ( doxercalciferol capsule )</keyword>
	<keyword>Hectorol速 ( doxercalciferol injection )</keyword>
</DOC>